Navigation Links
Life Sciences Industry Reaches Crossroad Say Noted Pillsbury Attorneys
Date:3/17/2008

r generic drug rivals to delay the introduction

of discount alternative products after hard-won patents expire.

-- Proposed legislation strengthening the federal government's hand in

negotiating bulk prescription drug purchases for Medicare recipients is

provoking intense lobbying and alliance-building efforts in Washington.

-- Despite regulatory uncertainty and free-market risks, 2007 was a record

year for venture capital investments in the life sciences, with an

estimated $12 billion focused on medical devices, biotechnology and

pharmaceuticals.

"2008 is a year of opportunity and major decisions for both the industry's titans and newly-minted players," Wetherell said. "With venture-backed and acquisitive entities seeking the lead in a finite number of promising areas, researchers are weighing the best business plans and merits of partners and alliances."

Regulators and legislators likewise offer choices while seeking to address the industry's growth and national importance.

"Crafting life science policy is challenging for lawmakers because competing motives are often attributed to 'Big Pharma,' universities, federal agencies or specific constituencies in established biotech regions," Main added. "The community's growing and varied ranks, coupled with many Americans pushing for universal healthcare are requiring life science companies to carefully examine policy aims and outcomes while crafting the right engagements and alliances."

Pillsbury's National Life Sciences Practice Team is comprised of lawyers and senior advisors with years of experience and industry-specific credentials in pharmaceutical, biotechnology healthcare, and agriculture. Practice members include lawyers with Ph.D.s and other advanced degrees in such fields as microbiology, chemistry, cellular biology, biochemistry, molecular biology, and physics, and include former judicial law clerks from the Court of
'/>"/>

SOURCE Pillsbury Winthrop Shaw Pittman LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/53wxp3/israel_biomedical ) has ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Sensors market is estimated at $0.19 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... 2015  US-Australian drug discovery company, Novogen Limited ... its comprehensive scientific review has identified high value ... of unmet patient need. Novogen is moving as ... prior to entering into Phase 1 clinical trials ... Chief Executive Officer, Iain Ross , said ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... ... (PGIs), as a high priority in the drug development approval process. Thus, innovator ... , This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Global & USA BioSimilar ... The highly awaited US Biosimilar market will ... awaited filigrastim biologic, Zarxio. How will the global market ... author reveals that biosimilars could save the US economy ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3
... 2012  /PRNewswire-Asia/ -- 3SBio Inc. (NASDAQ: SSRX ) ... focused on researching, developing, manufacturing and marketing biopharmaceutical products, ... quarter ended March 31, 2012. ... Total net revenues increased by 24.5% over the first ...
... tools and a state-of-the-art scanning transmission electron microscope, ... State University materials science and engineering researchers has ... metallic materials known as metallic glasses. Published ... Letters , the findings fill a gap in ...
... 10, 2012 BIOFUEL ENERGY CORP. (NASDAQ: BIOF), an ...  For the quarter ended March 31, 2012, the net loss ... a net loss of $9.0 million on revenues of $158.0 ... quarter ended March 31, 2012, the net loss attributable to ...
Cached Biology Technology:3SBio Inc. Announces Unaudited First Quarter 2012 Results 23SBio Inc. Announces Unaudited First Quarter 2012 Results 33SBio Inc. Announces Unaudited First Quarter 2012 Results 43SBio Inc. Announces Unaudited First Quarter 2012 Results 53SBio Inc. Announces Unaudited First Quarter 2012 Results 63SBio Inc. Announces Unaudited First Quarter 2012 Results 73SBio Inc. Announces Unaudited First Quarter 2012 Results 83SBio Inc. Announces Unaudited First Quarter 2012 Results 93SBio Inc. Announces Unaudited First Quarter 2012 Results 103SBio Inc. Announces Unaudited First Quarter 2012 Results 11In metallic glasses, researchers find a few new atomic structures 2In metallic glasses, researchers find a few new atomic structures 3BioFuel Energy Reports First Quarter 2012 Results 2BioFuel Energy Reports First Quarter 2012 Results 3BioFuel Energy Reports First Quarter 2012 Results 4
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
(Date:8/10/2015)... The latest 364 page report from business intelligence ... border security market . Visiongain assesses that ... Now: Border security is hard to achieve and harder ... issue you need to know about - and more importantly, ... how this will impact your company and the border security ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... indole-3-acetic acid (IAA), commonly referred to as auxin, plays ... Auxin influences development by affecting the expression of numerous ... cell expansion in specific plant tissues at specific stages ... roots, and floral organs to develop in the correct ...
... the June 20 issue of The Journal of Experimental ... by Colin Tinsley may have discovered how a normally ... , The human body harbors many harmless bacterial residents, ... makes its home in the upper respiratory tract, usually ...
... takes for a common, non-disease-causing virus to kill cervical, ... cultures, according to Penn State College of Medicine researchers. ... (AAV2), which infects the majority of the population but ... cancer cells yet has no effect on healthy cells," ...
Cached Biology News:Scientists find microRNAs regulate plant development 2Scientists find microRNAs regulate plant development 3Scientists find microRNAs regulate plant development 4Study: Harmless virus kills some cancers 2Study: Harmless virus kills some cancers 3
NATIVE, ENZYME PORCINE TRYPSIN...
G-Protein Coupled Receptor Assay, For 500 assays. SPA. Category: Drug Screening & Cellular Assays, Assays ....
EDTA, disodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99.0-101.0%, nuclease-free.Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemi...
Alkaline Phosphatase Stabilizer Solution, 1 L...
Biology Products: